How Andes Hantavirus Replicates and Spreads: The Science Behind the MV Hondius Cluster

The Biological Mechanics Driving Maritime Concern

As the expedition vessel MV Hondius remains anchored off Praia, Cape Verde, international public health authorities including the World Health Organization (WHO), the European Centre for Disease Prevention and Control (ECDC). Africa CDC are closely examining the pathogenic mechanisms of Andes orthohantavirus (ANDV). While orthohantaviruses are typically categorized as rodent-borne zoonoses acquired strictly via aerosolized excreta, Andes virus occupies a biologically distinct niche. It's the only known hantavirus conclusively showd to transmit directly from person to person. Understanding the cellular biology of Andes virus—from receptor recognition to intracellular replication and vascular disruption—explains why an isolated cluster aboard a passenger vessel represents a critical clinical and epidemiological challenge.

Viral Entry, Cap-Snatching, and Intracellular Replication

Andes orthohantavirus is an enveloped, negative-sense, single-stranded RNA virus belonging to the family Hantaviridae within the order Bunyavirales.Its tripartite genome consists of three segments designated Large (L), Medium (M). Minor (S), each encoding distinct structural and non-structural proteins essential for survival and replication within host cells. The viral envelope is studded with heterotetramers of surface glycoproteins, Gn and Gc, which are encoded by the M segment. These glycoproteins mediate attachment to host surface receptors. In human tissue, Andes virus primarily targets endothelial cells lining the microvasculature, exploiting cellular receptors such as beta-3 integrins, alongside secondary entry factors like decay-accelerating factor (DAF/CD55). Upon binding, the viral particle enters the cell through receptor-mediated endocytosis, often via clathrin-dependent or macropinocytic pathways. Once inside the acidified endosome, conformational shifts in Gc trigger viral envelope fusion with the endosomal membrane, releasing the viral ribonucleoprotein (RNP) complexes into the host cytoplasm. Unlike multiple other RNA viruses that replicate within specialized membranous cytoplasmic factories or the host nucleus, hantaviruses complete their replication cycle directly in the cytoplasm. Viral transcription relies on an RNA-dependent RNA polymerase (RdRp) encoded by the L segment. Because negative-sense RNA viruses can't directly translate viral messenger RNA (mRNA) without a 5-prime methylated cap, Andes virus employs a mechanism known as cap-snatching. The viral RdRp cleaves capped 5-prime oligonucleotides from host cellular mRNAs and uses them as primers to synthesize viral transcripts. Following primary transcription and protein translation, the S segment produces the nucleocapsid (N) protein, which encapsidates nascent viral genomic RNA. Progeny virions then assemble at the membrane of the Golgi complex before being transported via secretory vesicles to the plasma membrane for release through exocytosis.

The Mechanisms of Person-to-Person Spread

In standard ecological transmission, Andes virus is maintained in wild populations of the long-tailed pygmy rice rat (Oligoryzomys longicaudatus), endemic to southern Chile and southwestern Argentina. Spillover to humans occurs primarily when people inhale dried, aerosolized particles of rodent urine, droppings, or saliva. Yet, Andes virus diverges fundamentally from North American counterparts, such as Sin Nombre virus, and Old World strains, such as Puumala or Dobrava-Belgrade viruses. Multiple epidemiological investigations and laboratory models have confirmed that Andes virus can transmit directly between humans during intimate or sustained close contact. High viral RNA loads have been detected in the saliva, tracheal aspirates, and endotracheal secretions of infected individuals, especially during the late prodromal and early cardiopulmonary stages. Virologists believe that distinct structural variations in the Gn and Gc glycoproteins of Andes virus permit enhanced stability in human mucosal secretions, facilitating direct transmission through droplets, contaminated micro-aerosols, or deep respiratory interactions. In domestic and nosocomial settings historically documented in South America, secondary transmission risk was found to correlate strongly with bedroom sharing, prolonged domestic contact, or caregiving without comprehensive barrier precautions.

Why the MV Hondius Cluster Is Structurally Complex

The maritime environment of the MV Hondius combines epidemiological variables rarely encountered in terrestrial outbreaks:

1. Prolonged Confinement and Shared Airflows: Cruise and expedition vessels inherently feature enclosed communal dining areas, shared corridors, and common ventilation systems. While standard high-efficiency particulate air (HEPA) filtration can mitigate droplet dispersal in modern marine systems, prolonged cohabitation in confined quarters increases the cumulative probability of close-contact droplet or saliva transfer. 2. Long and Variable Incubation Periods: Andes hantavirus has an incubation period ranging from 7 to 39 days, with an average duration between two and three weeks. In an expedition scenario that originated in South America and sailed toward the North Atlantic, individuals infected at ports of call or initial land excursions may not exhibit symptoms until weeks into a trans-oceanic voyage, confounding point-source tracing. 3. Absence of Natural Reservoirs at Sea: Because Oligoryzomys longicaudatus is absent from marine vessels and West African coastal habitats, any ongoing or staggered emergence of symptoms within a voyage timeline points either to a prolonged chain of secondary human-to-human transmission or staggered exposures before departure.

Pathogenesis: From Cellular Entry to Pulmonary Edema

The clinical manifestation of Andes virus infection is Hantavirus Cardiopulmonary Syndrome (HCPS). The virus doesn't primarily kill host cells through lytic destruction. Instead, severe pathology is driven by an intense immune-mediated cytokine storm and severe microvascular dysregulation. As the virus replicates extensively within pulmonary and myocardial capillary endothelial cells, host cytotoxic T lymphocytes and macrophages infiltrate the tissue, releasing massive concentrations of pro-inflammatory cytokines—including tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6). Interferon-gamma (IFN-gamma). This hyperinflammatory state disrupts endothelial cell-to-cell junctions, notably vascular endothelial-cadherin (VE-cadherin) complexes. The consequence is catastrophic microvascular permeability. Plasma leaks uncontrollably into the alveolar spaces, drowning the lungs in non-cardiogenic pulmonary edema within hours of onset. Patients experience rapid progression from mild febrile prodromes—fever, myalgia, and gastrointestinal symptoms—to severe respiratory failure, profound hypotension, and cardiogenic shock. Since there are currently no globally approved targeted antivirals or licensed vaccines for Andes virus, patient survival depends almost entirely on early recognition, rigorous fluid management to prevent exacerbating pulmonary edema. Advanced critical care, including extracorporeal membrane oxygenation (ECMO). Health agencies monitoring the MV Hondius cluster continue to prioritize molecular diagnostic sequencing and isolation protocols to disrupt any remaining transmission networks.

Sources

• World Health Organization: https://www.who.int
• European Centre for Disease Prevention and Control: https://www.ecdc.europa.eu
• Africa Centres for Disease Control and Prevention: https://africacdc.org
• US Centers for Disease Control and Prevention: https://www.cdc.gov
• International Maritime Organization: https://www.imo.org